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1. Introduction
The genus Helicobacter belongs to the ε subdivision of the Proteobacteria, order Campylobac‐
terales,  family Helicobacteraceae.  Members of  this  genus are all  microaerophilic  organisms
and in most cases are catalase and oxidase positive, and many but not all species are also
urease positive [1].
In 1984, Warren and Marshall isolated a bacterium from human stomachs in some patients
with gastrointestinal disorders [2]. The organism was initially named “Campylobacter-like or‐
ganism”, “Campylobacter pyloridis” and “Campylobacter pylori”, and, after more studies, it is
named Helicobacter pylori (H. pylori) in recognition of the fact that this organism is distinct
from members of the genus Campylobacter [3].
H. pylori is a spiral-shaped Gram-negative flagellate bacterium that colonizes the human
stomach and can establish a long-term infection of the gastric mucosa. Since its isolation, its
infection has been associated to the development of various gastrointestinal diseases, such
as chronic gastritis, peptic ulcer disease, gastric MALT lymphoma and gastric cancer [1, 4-6].
Nowadays, it has also been related to some extradigestive diseases [7, 8], such as idiopathic
thrombocytopenic purpura [9], iron deficiency anemia [10], and hepatobiliary diseases [11,
12], and amongst others.
The prevalence of H. pylori infection varies widely by geographical area, age, race, and soci‐
oeconomic status [13]. Because it is not possible to ascertain when infection occurs clinically,
most of the information on the rates of H. pylori in geographically and demographically di‐
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verse populations comes from seroprevalence studies [14]. There have been numerous re‐
ports of a strong correlation between socioeconomic status and prevalence of infection.
Generally, low prevalence occurs in industrialized countries and higher prevalence rates
have been observed in underdeveloped and developing countries, possibly due to crowded
households, habits and lack of sanitary facilities [15-17].
Even though its transmission pathways are not completely clarified [18], the infection ap‐
pears to be usually acquired during childhood and is characterized as being chronic [19].
Routes of H. pylori transmission described include fecal-oral, oral-oral and gastric-oral. H. pylori
appears to be transmitted most readily within families, possibly from parent to child and
among siblings [20]. Evidence also supports child-to-child transmission among those in crowd‐
ed school or in some living conditions, while transmission among adults is considered rare [21].
After colonization, all patients with H. pylori infection develop histological gastritis, which
corresponds to classical chronic gastritis and is characterized by the infiltration of neutro‐
phils and other inflammatory cells. However, most patients are asymptomatic for life, while
only some will come to develop a digestive disease [22].
Colonization with H. pylori virtually leads to infiltration of the gastric mucosa in both an‐
trum and corpus with neutrophilic and mononuclear cells. Gastritis can be classified as an
acute or chronic gastritis and it can involve all parts of the stomach or just the fundus, corpus
or antrum. The chronic active gastritis is the primary condition related to H. pylori coloniza‐
tion, and other H. pylori-associated disorders, in particular, resulting from this chronic inflam‐
matory process [1], as atrophic gastritis (Figure 1) and intestinal metaplasia (Figure 2), causing
an elevated risk of gastric adenocarcinoma, both intestinal type and diffuse type [23].
Figure 1. Atrophic gastritis(Copyright © Center of Diagnosis of Digestive Diseases, State University of Campinas, SP,
Brazil. All rights reserved)
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Figure 2. – Intestinal metaplasia, prepyloric antrum(Copyright© Atlanta South Gastroenterology, P.C. All rights re‐
served)
However, the propensity to develop disease is an aspect that remains unclear, but may de‐
pend on host characteristics, particular bacterial factors (virulence of the infecting strains), or
to the specific interactions between host and microbe, besides the environmental factors [24].
In fact, the interest in H. pylori as a cause of gastric cancer began after the pioneering discov‐
eries of Marshall and Warren [2]. Prior to the isolation of the organism, it was know that
gastric adenocarcinomas typically arose in areas of gastritis. When the relationship between
H. pylori and chronic gastritis was established, investigators began to take interest in the
causal role of the bacterium in gastric cancer. Consequently, in 1994, the bacterium was clas‐
sified as a group I carcinogen by the International Agency for Research on Cancer and is re‐
garded as a primary factor for gastric cancer development [25].
The vast majority of gastric cancers are adenocarcinomas, which can be prevalently divid‐
ed into two types, the intestinal and the diffuse [26], which corresponds, respectively, to the
well-differentiated type and to the poorly-differentiated type, in the Japanese classification
[22]. In contrast to the diffuse type often associated with familial distribution and devel‐
oped in the stomach following chronic inflammation, especially in the cardia [27], intesti‐
nal type adenocarcinomas are generally thought to be preceded by a sequence of precursor
lesions [28]. The basic components of this process are chronic inflammation of the gastric
mucosa,  which  slowly  progresses  through the  premalignant  stages  of  atrophic  gastritis,
intestinal metaplasia and dysplasia to gastric cancer [29] that are most frequently localized
in the antrum [30].
Patients diagnosed in an early stage of the cancer (Figure 3) present an excellent prognosis,
with a five-year survival rate greater than 90%. In cases with advanced lesions, gastric can‐
cer carries a poor prognosis, with an overall five-year survival rate of less than 20% [31].
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Figure 3. – Early gastric adenocarcinoma(Copyright © Center of Diagnosis of Digestive Diseases, State University of
Campinas, SP, Brazil. All rights reserved)
With respect specifically to the bacterium strains, H. pylori has a high level of genetic diversi‐
ty that represents an important factor in its adaptation to the host stomach and also for the
clinical outcome of the infection [32,33]. Virulence factors of Helicobacter pylori are essential
players in modulating the immune response involved in the initiation of carcinogenesis in
the stomach. One category of the genes that are responsible for produce virulence factors is
the strain-specific ones, which are present in only some H. pylori strains [34]. Among then,
the best studied is the cytotoxin-associated gene pathogenicity island (cagPAI).
The cagPAI is a 40 kb region of chromosomal DNA encoding approximately 31 genes that
forms a type IV secretion system and can be divided into two regions, cag I and cag II, ac‐
cording to a novel insertion sequence [35]. This secretion system forms a pilus that delivers
CagA, an oncoprotein, into the cytosol of gastric epithelial cells through a rigid needle struc‐
ture covered by CagY, a VirB10-homologous protein and CagT, a Virb7-homologous pro‐
tein, at the base [36-38].
Upon delivery into host cells by the cag secretion system, the product of the terminal gene in
the island, CagA, undergoes Src-dependent tyrosine phosphorylation and activates an eukary‐
otic phosphatase (SHP-2), leading to dephosphorylation of host cell proteins and cellular
morphologic changes [39,40]. CagA has also been shown to dysregulate β-catenin signaling
[41,42] and apical-junctional complexes [43], events that have been linked to increased cell
motility and oncogenic transformation in a variety of models [44,45]. In addition, some stud‐
ies have been reported that the cagPAI appears to be involved in the induction of gastric
interleukin-8 (IL-8) production, a potent neutrophil-activating chemokine [46].
Consequently,  the presence of the cagA gene has been associated with higher grades of
inflammation, which may lead to the development of the most severe gastrointestinal diseas‐
es, such as peptic ulcer [47-49] and gastric cancer [50-54]. In Western countries, it has been
reported that individuals infected with cagA-positive strains of H. pylori are at a higher risk
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of peptic ulcer or gastric cancer than those infected with cagA-negative strains [34,55]. How‐
ever, in East Asia, most strains of H. pylori have the cagA gene irrespective of the disease [56].
Furthermore, cagA is a polymorphic gene that presents different numbers of repeat sequen‐
ces located in its 3’ region. Each repeat region of the CagA protein contains Glu-Pro-Ile-Tyr-
Ala (EPIYA) motifs, including a tyrosine phosphorylation site. The first repeat region is
commonly named as EPIYA-A and EPIYA-B segments and the second repeat region is
named EPIYA-C or EPIYA-D segments, for Western and East Asian strains, respectively
[57]. Despite the know variability in the N-terminal cagA gene and other cagPAI genes,
there has been limited information concerning clinical relevance of genetic variants outside
the EPIYAs [58].
Together with cagA gene, cagT gene is found at the base of the outgrowing pilus of the type
IV secretion system and is supposed to be responsible for binding to a cellular receptor to
induce interleukine-8 secretion and eject CagA [37]. The cagT gene has also been associated
with higher degrees of inflammation, being encountered in H. pylori strains from patients
with early and advanced gastric adenocarcinoma [54].
Thus, considering each gene, there are two types of clinical H. pylori isolate, CagA-produc‐
ing (cagA positive) strains and CagA-nonproducing (cagA negative) strains, and CagT-pro‐
ducing (cagT positive) strains and CagT-nonproducing (cagT negative) strains, genotypes
that were considered in this study.
As gastric cancer still ranks as a leading cause of cancer-related deaths in many parts of the
world, the aims of the present study were to investigate the presence of cagA and cagT
genes in Brazilian patients with early and advanced distal type intestinal adenocarcinoma,
in order to determine the general incidence of this gene in gastric cancer and to compare the
results obtained between the two stages of the disease, trying to understand if the cagA and
the cagT genes and/or the genotype cagAcagT could be important to the development of one
or other stage of distal intestinal type gastric adenocarcinoma in Brazil.
2. Clinical samples, methods and results
2.1. Clinical Samples
The present study was carried out utilizing clinical samples of H. pylori obtained from 2005
January to 2009 January from the Laboratory of Pathology of the Center of Diagnosis of Di‐
gestive Diseases, Faculty of Medical Sciences, State University of Campinas (UNICAMP),
São Paulo, Brazil. Eighty nine paraffin wax-embedded specimens of gastric tissue were ana‐
lysed from a total of 89 patients, 31 from patients diagnosed with early distal type intestinal
gastric adenocarcinoma (group one) and 58 from patients with advanced distal type intesti‐
nal gastric adenocarcinoma (group two). The mean ages of group one was 61.0 years, with
20 male cases (64.5%) and 11 female cases (35.5%). For group two the mean ages was 64.5
years, with 40 male cases (69.0%) and 18 female cases (31.0%). All the gastric tissue samples
were obtained from endoscopic biopsy and had positive results for H. pylori by histological
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analysis. H. pylori positive strains for cagA and cagT genes were used as a control for all the
reactions performed in this study. All the stages of this study were approved by the Ethics
Committee of the Faculty of Medical Sciences, State University of Campinas (UNICAMP),
São Paulo, Brazil.
2.2. Methods
2.2.1. DNA extraction
Paraffin wax-embedded tissue DNA extraction was performed by carrying out the pre-ex‐
traction treatment of fixed tissues, using xylene and ethanol washes for paraffin removal.
Subsequently, successive steps using proteinase K, phenol, chloroform and isoamyl alcohol
were carried out, in order to isolate and purify the DNA [59]. Quantification of the extracted
DNA and polymerase chain reaction (PCR) for human betaglobin gene [60] were carried out
in order to guarantee the quality of this research.
2.2.2. PCR for urease C gene, cagA gene and cagT gene
Primers pairs for all the genes are described in Table 1, as well as the length of the fragments
amplified for each reaction, urease C [61], cagA [62], and cagT [63]. PCR for urease C gene
was performed with the aim to identify the bacterium DNA in samples.
After amplification, each PCR product was submitted to eletrophoresis on a 2.0% agarose
gel stained by ethidium bromide with a 0.5X tris-acetate-EDTA buffer. A 100-bp ladder was
used as standard.
Then, for each specific reaction, after being tested positive for urease C gene, products ob‐
tained were classified in cagA positive or negative and cagT positive or negative.
Gene Strand Primer sequence (5´-3´) Length (bp)
betaglobin +
-
ACA CAA CTG TGT TCA CTA GC
CAA CTT CAT CCA CGT TTC ACC
110
urease C +
-
AAG CTT TTA GGG GTG TTA GGG GTT T
AAG CTT ACT TTC TAA CAC TAA CGC
294
cagA +
-
GAT AAC AGG CAA GCT TTT GAG G
CTG CAA AAG ATT GTT TGG CAG A
349
cagT +
-
CCA TGT TTA TAC GCC TGT GT
CAT CAC CAC ACC CTT TTG AT
301
Table 1. Sequence of synthetic oligonucleotide primers used to characterize H. pylori strains.
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2.2.3. Statistical Analysis
After the amplification reactions, the results were analysed by a chi-square test at the Statis‐
tical Service of the Faculty of Medical Sciences, State University of Campinas (UNICAMP),
with the Statistical Analysis for Windows ® (SAS) 9.1.3 (SAS Institute Inc, 2002-2003, Cary, NC,
USA). Results were then related to the diseases in study, observing possible differences
among H. pylori strains encountered in early and in advanced distal type intestinal gastric
adenocarcinoma. Values of p<0.05 were considered to be statistically significant. The results
as a whole, after comparison between the two groups, were depicted. Odd ratios with a con‐
fidence interval of 95% were also observed. Tables with absolute frequencies (n) and percen‐
tages (%) were made in order to determine genotypes combinations. Finally, Exact Fisher´s
Test was used to compare the genotypes combinations between early and advanced gastric
adenocarcinoma groups. Values of p<0.05 were considered to be statistically significant.
2.3. Results
PCR for the urease C gene of H. pylori was positive in all 89 samples, identifying the bacteri‐
um DNA (Table 2). Analyzing the results obtained for cagA gene, from patients with early
gastric cancer, 61.3% (19 cases) were positive and from patients with advanced gastric can‐
cer, 82.8% (48 cases) were positive, with a p = 0.025 (OR = 3.032; 95% CI = 1.123-8.185) (Table
2; Figure 4). In the group as a whole, there were 67 positive cases (75.3%) for the cagA gene.
As regards to cagT gene of H. pylori, from patients with early gastric adenocarcinoma, 54.8%
(17 cases) were positive and, in patients with advanced gastric cancer, 65.5% (38 cases) were
positive, with a p = 0.323 (OR = 1.565; 95% CI = 0.642-3.813). (Table 3; Figure 5) In the group
as a whole, there were 55 positive cases (61.8%) for the cagT gene.
Classification Early gastric cancer Advanced gastric cancer Total p value
urease C 31 (100.0%) 58 (100.0%) 89 (100.0%)
cagA positive
cagA negative
19 (61.3%)
12 (38.7%)
48 (82.8%)
10 (17.2%)
89 (100.0%) 0.025*
cagT positive
cagT negative
17 (54.8%)
14 (45.2%)
38 (65.5%)
20 (34.5%)
89 (100.0%) 0.323
Total 31 (100.0%) 58 (100.0%) 89 (100.0%)
Table 2. General results obtained after PCRs for urease C, cagA and cagT genes of H. pylori. * cagA gene (p=0.025)
OR=3.032, 95% CI = 1.123-8.185)
 
From Gastritis to Gastric Cancer: The Importance of CagPAI of Helicobacter Pylori on the Development of Early and
Advanced Gastric Adenocarcinoma
http://dx.doi.org/10.5772/53208
229
Figure 4. Amplification of cagA gene of H. pylori (349 bp). L, ladder 100 bp; C+, positive control; 01-05, positive sam‐
ples for cagA gene; C-, negative control.
Figure 5. Amplification of cagT gene of H. pylori (301 bp). L, ladder 100 bp; C+, positive control; 01-05, positive sam‐
ples for cagT gene; C-, negative control.
After the individual analysis, a table with absolute frequencies (n) and percentages (%) was
made in order to compare the results individually for each gene and the genotypes combina‐
tions (Table 3; Table 4, respectively). There were 75.28% of positive cases for cagA gene and
61.80% of positive cases for cagT gene (table 3). As regards to cagAcagT, the most frequent
genotype was cagA+cagT+, that was presented in 52.81% of the samples (table 4). The sec‐
ond most frequent genotype was cagA+cagT-, presented in 22.47% of the samples (table 4).
Subsequently, the combinations of genotypes were made and then compared between the
two groups of patients, with early and advanced gastric adenocarcinoma. Although the
most frequent genotype (cagA+cagT+) was the same in both groups of patiens, there was
found a statistically significant difference between the groups, with cagA+cagT+ in ad‐
vanced gastric cancer group (62.07%, 36 cases) and with cagA-cagT+ in early gastric cancer
group (19.35%, 6 cases), p=0.027 (table 5).
Current Topics in Gastritis - 2012230
Genes Frequency (n) Percentage (%)
cagA negative 22 24.72
cagA positive 67 75.28
cagT negative 34 38.20
cagT positive 55 61.80
Table 3. Descriptive analysis of categorical variables for total samples
cagA cagT combination Frequency (n) Percentage (%)
cagA cagT
negative negative 14 15.73
negative positive 8 8.99
positive negative 20 22.47
positive positive 47 52.81
Table 4. Descriptive analysis of categorical variables for total samples according to genotype (cagAcagT)
cagAcagT Advanced
gastric cancer
Early
Gastric cancer
Total
negative negative 8
13.79
6
19.35
14
negative positive 2
3.45
6
19.35
8
positive negative 12
20.69
8
25.81
20
positive positive 36
62.07
11
35.48
47
Total 58 31 89
Table 5. - Genotypes comparison between the two groups of patients, advanced and early gastric cancerp = 0.027
3. Conclusion
Gastritis is the most common illness associated to the stomach and can be considered as the
beginning of different complication that may led to peptic ulcers disease and gastric adeno‐
carcinoma. Specifically concerning to gastric cancer, the understanding of the development
of this disease has advanced considerably in recent decades, especially as regards to the role
of H. pylori (the principal etiologic agent) in the progression of chronic gastritis in precancer‐
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ous lesions and cancer, changes that occur in the gastric mucosa in the development of the
intestinal type gastric adenocarcinoma [30].
The risk of development of this disease is also related to genetic characteristics of the host
and environmental factors, which, associated with specific bacterium strain characteristics,
influence the severity of the chronic inflammatory response [64]. Thus, although infection
with H. pylori almost always results in chronic active gastritis, many infected patients do not
develop any complication, even those not showing clinical symptoms of infection [65]. This
leads to the conclusion that some strains are more virulent than others [1], expressing, in dif‐
ferent ways, specific bacterial products.
Other question that remains unclear, and that can be associated with these bacterium viru‐
lence factors, is why some tumors remain in the early stage and others are in advanced stage
almost always in a short period of time? Are the different strains of H. pylori important to
these changes? And, if the bacterium is eradicated, when this eradication is important? Is
there a point of the development of the cancer when the eradication is not more important
or when the bacterium presence does not make a difference?
In the present study we tried to understand some of these questions considering only one
aspect of the development of the cancer, which were H. pylori strains presented in Brazilian
patients with early and advanced distal type intestinal gastric adenocarcinoma. Considering
the mentioned issues and a large number of studies that demonstrate that the cagPAI as one
of the most important virulence factors of H. pylori, associated with higher grades of mucosa
inflammation, we studied two genes that is in the cagPAI, the cagA and the cagT genes.
As regards to cagA gene, in an isolated analysis, our results were similar to those of in
which strains cagA positive were related to the development of gastric cancer. cagA positive
strains tend to be more virulent and induce higher levels of expression of cytokines such as
interleukin 1b and 8 [66]. Some studies have shown that patients with strains that express
CagA are three times more likely to develop gastric cancer (52,57,67] than those infected
with cagA negative strains [56,68]. Besides, other study demonstrated that strains that ex‐
press CagA are three times more likely to develop advanced gastric cancer than the early
stage [54]. In the present study the same characteristics were observed and patients infected
with cagA positive strains demonstrated a high risk of advanced gastric cancer development
(p=0.025; OR=3.023, 95%CI). Besides, studies conducted in Western countries [69,70] and in
Asian countries [71] reported that the most patients with gastric cancer are infected with H.
pylori cagA positive strains.
One limitation for the comparisons of our results with others were that our study classified
the two stages of the gastric cancer, the early and the advanced ones, and the most part of
the studies consider only the gastric cancer disease, without classifying it in early or ad‐
vanced stages. Besides, it was not our aim the study of the polymorphism of this gene,
which are related to the EPIYA motifs, which can be important if we considerer the cagA
gene in an isolated analysis, even though there has been limited information concerning
clinical relevance of genetic variants outside the EPIYAs.
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With our results, we can conclude that cagA gene is important for the development both of
early and advanced gastric cancer, because it was presented in the most part of the strains in
the two stages of the disease. Nevertheless, we can not conclude if it is important for the
change of one stage in other (early in advanced stage) and we have also to consider that we
do not really know if the bacterium presence is important or crucial after the beginning of
the development of the disease. Some studies have demonstrated that the eradication of H.
pylori when the precancerous lesions are present can be very important to prevent the cancer
development, but, after this development beginning, we do not know if the regression of the
early gastric cancer lesions can occur with the bacterium eradication.
Like the cagA gene, the cagT also belongs to the cagPAI and it is assumed that is related to
the type IV secretion system, responsible for binding to cell receptors and inducing the re‐
lease of interleukin-8 and also by ejecting the CagA protein [37]. The cagT gene has been
linked to the development of peptic ulcer, and strains with the absence of this gene were
generally related to chronic gastritis [63]. In this study, values were not found to be statisti‐
cally significant between the two studied groups (p=0.323). However, the cagT gene was
found, in the group as a whole, in 61.8% of the samples, which reflects an important result,
showing that this gene, like cagA, or acting together with cagA, may be related to the gastric
cancer development.
As regards to the comparison of the genotype cagAcagT, we reported again as a limitation
for our study the fact that there are no studies that consider the early and the advanced
stages of gastric cancer separately, so there were no relevant studies with which to compare
the results from different stages of the same disease, gastric cancer. Further, we considered it
unnecessary to make a comparison between these results and possible results from healthy
individuals, because our aim was exactly to compare the strains presented in two stages of
the same disease and not between the strains in the disease and in healthy volunteers.
For both groups, advanced and early, the most frequent genotype was cagA+cagT+ (62.07%
and 35.48%, respectively). However, when comparison between the two groups was made,
we found a statistically significance concerning the cagA+cagT+ and cagA-cagT+ strains
(p=0.027). It can be considered very important because even though the genes cagA+ and
cagT+ status were more frequent in both groups, the genotype cagA-cagT+ occurred with a
higher frequency in the early gastric cancer group (advanced = 3.45%; early = 19.35%). More‐
over, the genotype cagA+cagT+ occurred with a higher frequency in the advanced cancer
group, a result that can be considered important too (advanced = 62.07%; early = 35.48%).
We can suggest, with these results, that cagA gene positivity, independently of its polymor‐
phisms, can be considered an essential virulence factor for the development of most severe
gastric diseases, as gastric cancer.
Finally, as told before, the understanding of gastric carcinogenesis has advanced considera‐
bly over the past decades, especially with regards to insights into the role of H. pylori infec‐
tion and the progression of chronic gastritis from premalignant stages to gastric cancer.
Thereby, with the results obtained in the present study, cagA and cagT genes can be consid‐
ered important H. pylori virulence factors implicated on the gastric cancer development.
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Obviously, more studies are necessary to elucidate the H. pylori mechanisms of gastric tissue
injury and we can also suggest that the identification of strains positive for cagA and cagT
genes, besides others that are just considered virulence factors, can become very important
and an useful tool to identify subjects most at risk for cancer, especially in places when this
disease presents a higher incidence.
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